People
Founder and Principal Investigator
PhD in Pharmaceutical Sciences (computational chemistry; CHARMM force-field development with Alexander D. MacKerell Jr.), M.Sc. in Chemistry, B.Sc. in Biochemistry. Founder of Global-Chem, President of Standard Seed Corporation, with experience coordinating large multi-team neuroscience and animal-behavior data consortia.
2024–present
Computational drug discovery, docking and MD workflows; leads COPTIS product testing.
2025–present
Research operations and partnerships.
2025–present
Computational chemistry.
2025–present
Computational chemistry and solubility screening.
2025–present
Software engineering.
2023–2025
AI-driven de novo design (Eg5 inhibitor paper, Computers in Biology and Medicine, 2025).
2024–2025
Group member.
2024
High-school researcher, Global-Chem.
Quantum chemistry and MD
Computer vision and animal models
Machining, thermodynamics and data acquisition